Updates in the Treatment of Metastatic Breast Cancer

Monday, December 5, 2022

4:00 PM – 5:00 PM

Location: Mandalay Bay South Convention Center, Oceanside D, Level 2

CE Credits: 1.00 contact hours

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists
Activity #: 0204-0000-22-255-L01-P
Activity Type: Application-based
Target Audience: Pharmacist

Learning Objectives:

Develop patient care plans that reflect current guideline recommendations and new evidence for metastatic breast cancer.
Develop a supportive care plan for preventing skeletal-related fractures for metastatic breast cancer patients.
Identify adverse drug reactions of cancer treatments in patients with metastatic breast cancer.
Recommend management strategies for adverse drug reactions to cancer treatment in patients with metastatic breast cancer.

Program Chair(s)

Bradi L. Frei, PharmD, MSc, BCOP, BCPS

Professor and Oncology Clinical Pharmacist
University of the Incarnate Word and UT Health San Antonio MD Anderson Cancer Center

Moderator(s)

Bradi L. Frei, PharmD, MSc, BCOP, BCPS

Professor and Oncology Clinical Pharmacist
University of the Incarnate Word and UT Health San Antonio MD Anderson Cancer Center

Faculty Member(s)

Bradi L. Frei, PharmD, MSc, BCOP, BCPS

Professor and Oncology Clinical Pharmacist
University of the Incarnate Word and UT Health San Antonio MD Anderson Cancer Center